Literature DB >> 11090982

The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy.

T Kimura1, M P Takahashi, Y Okuda, M Kaido, H Fujimura, T Yanagihara, S Sakoda.   

Abstract

We investigated gene expression patterns of ion channels including the apamin-sensitive small-conductance Ca(2+)-activated K(+) (SK3) channel, the adult isoform of the skeletal muscle Na(+) channel (SkM1), the fetal isoform of skeletal muscle Na(+) channel (H1), and the Cl(-) channel (ClC-1) by using the semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for muscle samples from patients with adult onset myotonic dystrophy (DM), amyotrophic lateral sclerosis, and polymyositis. Patients with DM showed a significant increase in SK3 mRNA but not in mRNAs for other ion channels. The increased expression of SK3 gene in DM did not correlate with H1, the marker of muscle denervation, or the percentage of type 2C fiber, the marker of muscle regeneration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090982     DOI: 10.1016/s0304-3940(00)01598-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Small-conductance calcium-activated potassium currents in mouse hyperexcitable denervated skeletal muscle.

Authors:  T R Neelands; P S Herson; D Jacobson; J P Adelman; J Maylie
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

2.  Expression of small-conductance calcium-activated potassium channels (SK3) in skeletal muscle: regulation by muscle activity.

Authors:  Morgana Favero; De-Jian Jiang; Christian Chiamulera; Alberto Cangiano; Guido Francesco Fumagalli
Journal:  J Physiol       Date:  2008-08-14       Impact factor: 5.182

3.  Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform.

Authors:  Geetika Sethi; Gaurav Chopra; Ram Samudrala
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

4.  Age-dependent chloride channel expression in skeletal muscle fibres of normal and HSA(LR) myotonic mice.

Authors:  Marino DiFranco; Carl Yu; Marbella Quiñonez; Julio L Vergara
Journal:  J Physiol       Date:  2012-12-17       Impact factor: 5.182

Review 5.  Myotonic Dystrophy Type 1 Management and Therapeutics.

Authors:  Cheryl A Smith; Laurie Gutmann
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

6.  Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling.

Authors:  Takashi Kimura; John D Lueck; Peta J Harvey; Suzy M Pace; Noriaki Ikemoto; Marco G Casarotto; Robert T Dirksen; Angela F Dulhunty
Journal:  Cell Calcium       Date:  2009-01-07       Impact factor: 6.817

7.  Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.

Authors:  Annalisa Botta; Laura Vallo; Fabrizio Rinaldi; Emanuela Bonifazi; Francesca Amati; Michela Biancolella; Stefano Gambardella; Enzo Mancinelli; Corrado Angelini; Giovanni Meola; Giuseppe Novelli
Journal:  Gene Expr       Date:  2007

8.  Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.

Authors:  F Rinaldi; A Botta; L Vallo; G Contino; A Morgante; R Iraci; C Catalli; G Silvestri; V M Ventriglia; L Politano; G Novelli
Journal:  Acta Myol       Date:  2008-12

Review 9.  Targets and regulation of microRNA-652-3p in homoeostasis and disease.

Authors:  Maxwell T Stevens; Bernadette M Saunders
Journal:  J Mol Med (Berl)       Date:  2021-03-12       Impact factor: 4.599

10.  Altered Ca2+ homeostasis and endoplasmic reticulum stress in myotonic dystrophy type 1 muscle cells.

Authors:  Annalisa Botta; Adriana Malena; Emanuele Loro; Giulia Del Moro; Matteo Suman; Boris Pantic; Gyorgy Szabadkai; Lodovica Vergani
Journal:  Genes (Basel)       Date:  2013-06-04       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.